Publications by authors named "Pengmin Ji"

Claim this Profile
K
Knockout of Trpc6 attenuates T2DM-induced liver injury and inflammation by inhibiting CN-NFAT2-NLRP3 signalling in mice.
Yan Liu, Yinglin Fu, Guohang Wang, Yong Su, Ran Sun, Pengmin Ji

Pathol Res Pract· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Ginsenoside Rg1 attenuates T2DM-induced renal damage and fibrosis by inhibiting TRPC6-ChREBP-TXNIP signaling.
Hui Zhang, Haoyu Liang, Lei Fan, Xing Zhu, Pengmin Ji

J Ethnopharmacol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Ginsenoside Rg1 alleviates chronic inflammation-induced neuronal ferroptosis and cognitive impairments via regulation of AIM2 - Nrf2 signaling pathway.
Liangliang Kong, Yan Liu, Jingwei Li, Yanyan Wang, Pengmin Ji

J Ethnopharmacol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Ginsenoside Rg1 attenuates lipopolysaccharide-induced chronic liver damage by activating Nrf2 signaling and inhibiting inflammasomes in hepatic cells.
Huimin Zhou, Yan Liu, Yong Su, Pengmin Ji, Liangliang Kong

J Ethnopharmacol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Ginsenoside Rg1 attenuates LPS-induced chronic renal injury by inhibiting NOX4-NLRP3 signaling in mice." [Biomed. Pharmacother. 150 (2022) 112936].
Duoduo Zhang, Pengmin Ji, Ran Sun, Huimin Zhou, Lei Huang

Biomed Pharmacother· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Ginsenoside Rg1 treatment alleviates renal fibrosis by inhibiting the NOX4-MAPK pathway in T2DM mice.
Pengmin Ji, Qifeng Shi, Yan Liu, Min Han, Yong Su

Ren Fail· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interruption of TRPC6-NFATC1 signaling inhibits NADPH oxidase 4 and VSMCs phenotypic switch in intracranial aneurysm.
Zheng-Hao Sun, Fei Liu, Liang-Liang Kong, Peng-Min Ji, Lei Huang, Jing Luo

Biomed Pharmacother· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Ginsenoside Rg1 treatment protects against cognitive dysfunction via inhibiting PLC-CN-NFAT1 signaling in T2DM mice.
Xianan Dong, Liangliang Kong, Lei Huang, Yong Su, Xuewang Li, Pengmin Ji

J Ginseng Res· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Ginsenoside Rg1 alleviates learning and memory impairments and Aβ disposition through inhibiting NLRP1 inflammasome and autophagy dysfunction in APP/PS1 mice.
Xuewang Li, Lei Huang, Liangliang Kong, Yong Su, Huimin Zhou, Pengmin Ji

Mol Med Rep· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stress level of glucocorticoid exacerbates neuronal damage and Aβ production through activating NLRP1 inflammasome in primary cultured hippocampal neurons of APP-PS1 mice.
Liu Yang, Huimin Zhou, Lei Huang, Yong Su, Liangliang Kong, Pengmin Ji

Int Immunopharmacol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Ginsenoside Rg1 attenuates LPS-induced chronic renal injury by inhibiting NOX4-NLRP3 signaling in mice.
Duoduo Zhang, Pengmin Ji, Ran Sun, Huimin Zhou, Lei Huang

Biomed Pharmacother· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis